My sinuses have been bunged up for years. I'm constantly blowing my nose. I use nasal decongestants but those don't seem to ...

People with allergic fungal rhinosinusitis taking Dupixent (dupilumab) saw significant improvement in congestion and sinus ...

A causal relationship appears to exist between increased air pollution and outpatient visits for chronic rhinitis, according to a study published in The Laryngoscope. Su Hwan Kim, from Gyeongsang ...

BROADEN2 Phase 2b trial in atopic dermatitis (AD) ongoing, with data expected by mid-2027 KT-621 BREADTH Phase 2b trial in asthma ongoing, with data expected in late-2027 Initiated dosing in KT-579 ...

The AIM-listed immunotherapy specialist will present three posters at the AAAAI Annual Meeting in Philadelphia this week ...

Tree pollen levels are currently "very high" in London, while levels are "high" in areas including Birmingham, Brighton, ...

Rise in prevalence of allergy cases and surge in focus on personalized medicine are the major factors that drive the growth of the allergy immunotherapy market. However, the risk of side effects ...

Many Texarkana residents are already feeling the effects of spring allergy season, from sneezing to watery eyes and ...

Neurent Medical today announced positive findings from a randomized controlled trial evaluating its Neuromark system.

Dupixent (dupilumab) is now FDA-approved for adults and children aged 6 years and older with allergic fungal rhinosinusitis and prior sino-nasal surgery.

Neurent Medical, a leader in non-surgical treatments for chronic rhinitis, today announced the publication of positive results from its randomized controlled trial (RCT) evaluating the NEUROMARK® ...

Approval in adults and children aged 6 years and older supported by Phase 3 trial demonstrating Dupixent significantly reduced nasal signs and ...